Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, with a minimal navigation header indicating an access issue. This reflects restricted access rather than a content update.SummaryDifference18%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAn NIH grant/contract attribution for 2015 was added, and the page revision text was updated from v3.6.5 to v3.6.6, reflecting a minor version update in the page’s metadata.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page's revision tag updated from v3.6.4 to v3.6.5, indicating a new version of the page.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor update to the page's backend or UI. The study content appears unchanged.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a new build/version of the page.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page shows a new revision tag: from v3.6.0 to v3.6.2, signaling a newer version of the page software. This reflects maintenance or bug fixes rather than updates to the study content.SummaryDifference0.1%

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.